JUN 03, 2019 4:35 PM PDT

Proton therapy reduces risk of side effects

New research to be presented at the American Society of Clinical Oncology's annual meeting in Chicago this year by a radiation oncologist Dr. Brian C. Baumann highlights the benefits of proton therapy over x-ray radiation. While these two cancer treatments have relatively the same cure rates for cancer, Dr. Baumann’s findings suggest that the risk of severe side effects is much lower with proton therapy, while those patients undergoing x-ray radiation often experience many side effects, including fatigue, skin irritation, fever, nausea, vomiting, and diarrhea, as well as changes in appetite or difficulty eating and swallowing.

The American Cancer Society estimates that in 2019, doctors will have diagnosed 1,762,450 new cases of cancer, and 606,880 people will have died from the disease. While effective treatments like radiation are crucial for patients, quality of care is also an important aspect of deciding a treatment plan.

Proton therapy is also called proton beam therapy and works by firing photons at tumors in order to eradicate them. Watch the video below to get a better understanding of the technology behind this treatment.

In order to come to the conclusions of the study, Dr. Baumann and his team looked at 1,500 people with many different types of cancer. They analyzed the experiences of patients who received proton chemoradiotherapy compared to those of patients who received x-ray chemoradiotherapy.

"Proton therapy was associated with a substantial reduction in the rates of severe, acute side effects — those that cause unplanned hospitalizations or trips to the emergency room — compared with conventional photon, or X-ray, radiation for patients treated with concurrent radiation and chemotherapy,” said Dr. Brian Baumann.

The substantial reduction that Dr. Baumann mentions is indeed significant: people who received proton therapy had a relative risk of severe side effects within 90 treatment days two-thirds lower than patients who received X-ray radiation.

This research could have great potential for helping patients and their practitioners make tough decisions regarding cancer treatment options.

New research suggests proton therapy could greatly reduce the risk of side effects. Photo: MedStar Georgetown University Hospital

Sources: Medical News Today, ASCO

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 23, 2020
Clinical & Molecular DX
Prostate Cancer: To Treat or Not to Treat
JUL 23, 2020
Prostate Cancer: To Treat or Not to Treat
After a prostate cancer diagnosis, urologists do not always initiate immediate clinical intervention. In those with Low- ...
AUG 03, 2020
Cell & Molecular Biology
Gut Microbes & Diet Change the Behavior of a Cancer-Driving Protein
AUG 03, 2020
Gut Microbes & Diet Change the Behavior of a Cancer-Driving Protein
Clinicians and researchers have long wondered why cancer is the small intestine is rare while it's so common in the colo ...
AUG 07, 2020
Cancer
How Down Syndrome genes safeguard against solid tumors
AUG 07, 2020
How Down Syndrome genes safeguard against solid tumors
Are people with Down syndrome protected from developing solid tumors in some way? So suggests new research published in ...
AUG 09, 2020
Cancer
Reducing post-surgery metastasis in colorectal cancer patients
AUG 09, 2020
Reducing post-surgery metastasis in colorectal cancer patients
Scientists have recently shown the successful reduction of metastasis in post-surgery colorectal cancer patients. The st ...
AUG 16, 2020
Cancer
Cancer mapping shows health disparities in remote areas
AUG 16, 2020
Cancer mapping shows health disparities in remote areas
Scientists mapping cancer statistics have developed a new mathematical model to track health inequalities relating to th ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
Loading Comments...